$ATAI received 3 mentions from 2 distinct FinTwit voices over a 12-month period, with the first mention on March 31, 2026, and the most recent on April 20, 2026. @investmentguru_ was the most active voice discussing the ticker, contributing 2 mentions, while @adamfeuerstein contributed 1 mention. The discussions focused on $ATAI's position in the psychedelic biotech space, particularly its ownership of DemeRx and Phase 1 ibogaine data, and its backing by Peter Thiel.